Australia: Using health information for research – key privacy considerations for medical technology companies

Services: Competition & Consumer Law, Intellectual Property & Technology, People & Workplace
Industry Focus: Life Sciences & Healthcare

What you need to know

  • Medical technology companies are often keen to access health information for research and development.
  • Australia's privacy legal framework places restrictions on the use of health information for such purposes, particularly with respect to consent, de-identification and transfer of information overseas.
  • This article examines these three key issues which medical technology companies should consider before using health information for research, and outlines some suggested strategies and best practices around how those issues can be addressed.

Medical technology companies are keen to access health information for a variety of purposes beyond the delivery of their products and services.

Research and development is one of these purposes. Through research, medical technology companies seek to improve their products and create better outcomes for individual patients. These improvements may also reduce the burden of health funding on government, private health insurers and patients.

However, Australia's privacy legal framework places restrictions on the use of health information for research.

Here are the three key issues that medical technology companies should consider before using health information for research purposes, and some suggested strategies and best practices around how they can be addressed.

  1. Consent

Generally, medical technology companies are permitted to use and disclose an individual's health information if it is related to the dominant reason that the company collected the individual's information in the first place (the primary purpose).

Medical technology companies usually collect health information when delivering their products (and associated healthcare services) to individuals. The 'primary purpose' is therefore to enable delivery of those products and services.

If a medical technology company wishes to use an individual's health information for a secondary purpose, such as research to monitor features and treatment outcomes associated with its product or services, it must obtain the individual's consent to do so.

The Office of the Australian Information Commissioner (OAIC) has identified these key features of consent:

  • an individual must be adequately informed before giving consent
  • the individual must give consent voluntarily
  • the consent must be current and specific, and
  • the individual must have capacity to understand and communicate their consent. 1

To ensure the requirements of consent are met in practice, several measures can assist including:

  • using clear and plain language to explain what the consent is being provided for
  • setting out what will happen to an individual's information, each step of the way, and
  • being specific about what the consent is for, and how long it will last.

There is an important balance for medical technology companies between being specific about how they will use health information, and ensuring that the consent is broad enough to cover future uses (to avoid the need to go through the consent process again).

  1. De-identification

De-identification allows medical technology companies to use health information for research without the need to obtain the consent of individuals.

Personal (including health) information is de-identified if the information is no longer about an identifiable individual or an individual who is reasonably identifiable (section 6(1) of Privacy Act 1988 (Cth)). Handling de-identified information is not governed by the Privacy Act.

But what does 'de-identifying' really look like in practice? There is no simple 'checklist' of identifiers which must be removed in order for information to become de-identified. Removing the obvious personal identifiers such as the name, address and date of birth of an individual is essential, but other steps might also need to be taken to truly de-identify personal information. This might include removing or modifying information about unusual characteristics of an individual (such as occupation, languages spoken, age and unique background medical features).

Also, whether health information is effectively de-identified depends on what other information is available to persons using the information.

For example, information that an unnamed person with a certain medical condition lives in a specific postcode area may not on its own enable the individual to be identified, so would not be personal information. On the other hand, if the information is held by an organisation with specific knowledge that could link an individual to the medical condition and the postcode, it may be personal information.2

The key question for medical technology companies is: how to separate records containing de-identified data for research purposes from records containing personal information associated with treatment of patients?

The OAIC has indicated that the risk of re-identification must be actively assessed and managed to ensure that the risk of re-identification is low. Relevant factors to consider when determining whether information has been effectively de-identified include the cost, difficulty, practicality and likelihood of re-identification.3

In practice, this means that medical technology companies should establish safeguards to separate identifiable information collected and associated with supplying products and services to individuals, from de-identifiable information used in research and development activities. Possible precautions range from implementing protocols to ensure that personnel do not attempt to re-identify information to engaging experts to determine methods of mitigating the risk of linking different sets of information.

  1. Transfer of information overseas

Australian medical technology companies often wish to transfer health information overseas, and in particular to parent companies' global or regional headquarters, so that it can be used in worldwide research projects.

Australian Privacy Principle (APP) 8 governs the disclosure / transfer of personal information by a medical technology company to a different entity (including a related company) offshore. APP 8 makes it clear that before an Australian medical technology company discloses personal information to an overseas recipient, it must take reasonable steps to ensure that the offshore entity will comply with (not breach) the APPs. Usually this can be achieved through appropriate contractual provisions - for example, those which require the overseas recipient to comply with the APPs.

However, generally speaking, a medical technology company will be liable for the acts or omissions of the overseas recipient if those activities breach the APPs. There are limited exceptions to this rule and it is unlikely that these exceptions will be able to be relied upon in the event of a breach by the overseas recipient.

This means that an Australian medical technology company should review its contractual arrangements to ensure that overseas entities undertake to comply with the APPs, and that overseas entities indemnify them in the event of breaches, before the Australian company releases personal information offshore.

Key takeaways

A medical technology company seeking to use health information for research and development purposes should:

  • be mindful of the obligation to obtain an individual's consent to use their health information for such purposes, and ensure consent is appropriately obtained
  • consider whether health information can be suitably de-identified for use in research and development, which includes assessing the risk of re-identification, and
  • ensure its contractual arrangements with overseas parties include undertakings for those parties to comply with the APPs and to indemnify the Australian company for any breach, before transferring any health information to those overseas parties.


1 OAIC, Australian Privacy Principle Guidelines (1 April 2015), paragraph B.34.
2 Ibid, paragraph B.92.
3 OAIC, Privacy business resource 4: De-identification of data and information (April 2014).

This article is intended to provide commentary and general information. It should not be relied upon as legal advice. Formal legal advice should be sought in particular transactions or on matters of interest arising from this article. Authors listed may not be admitted in all states and territories

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions